ArticleJournal of thoracic disease2025
The amount of mediastinal lymph nodes dissected in robot-assisted cervical esophagectomy-an experimental cadaver study.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Transthoracic esophagectomy (TTE) is the preferred approach for curative esophageal cancer. However, concomitant single-lung ventilation limits its use in patients with compromised cardio-pulmonary function. Transhiatal esophagectomy (THE) grants two-lung ventilation yet offers a limited mediastinal lymphadenectomy and is only suitable for distal tumors. A promising alternative is robot-assisted cervical esophagectomy (RACE). Initial studies show its feasibility, yet, the mediastinal lymph node yield (LNY) is unknown. The aim of this study is to describe the accessibility of the lymph node stations (LNS) and to analyze to which extent the mediastinal LNS can be resected during the cervical phase of RACE. Methods: Experienced robotic upper-gastrointestinal (GI) surgeons performed cervical esophagectomy and mediastinal lymphadenectomy on 4 cadavers using a "da Vinci Xi" surgical system through a left cervical approach. Target LNS were 4R, 4L, 5 and 7, as defined by Naruke. Resected tissues were categorized as primary-esophagus and lymph nodes (LNs) resected through RACE- or secondary-residual LNs post-RACE- resected tissue and were analyzed by experienced pathologists. LNs were counted for every station. Results: Station 4R yielded a median of 16 LNs primarily and 12 secondarily; station 4L: 17 primarily, 0 secondarily; station 5: 4 primarily, 7 secondarily; and for station 7: 9 primarily and 5 secondarily. Conclusions: This study shows that the RACE procedure delivers a limited mediastinal lymphadenectomy. LNS 4L can be fully resected. Stations 4R, 5 and 7 could be partially resected. The RACE procedure may, however, be a viable alternative for patients who cannot undergo a TTE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.